Cargando…

A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)

OBJECTIVE: To evaluate the efficacy and tolerability of single pulse transcranial magnetic stimulation (sTMS) for the preventive treatment of migraine. BACKGROUND: sTMS was originally developed for the acute treatment of migraine with aura. Open label experience has suggested a preventive benefit. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Starling, Amaal J, Tepper, Stewart J, Marmura, Michael J, Shamim, Ejaz A, Robbins, Matthew S, Hindiyeh, Nada, Charles, Andrew C, Goadsby, Peter J, Lipton, Richard B, Silberstein, Stephen D, Gelfand, Amy A, Chiacchierini, Richard P, Dodick, David W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944078/ https://www.ncbi.nlm.nih.gov/pubmed/29504483 http://dx.doi.org/10.1177/0333102418762525

Ejemplares similares

Post market pilot programme with single pulse transcranial magnetic stimulation (sTMS) for acute treatment of migraine: SpringTMS™ use in migraine
por: Weatherall, MW, et al.
Publicado: (2013)

Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program
por: Bhola, Ria, et al.
Publicado: (2015)

EHMTI-0379. Update of the uk post market pilot programme with single pulse transcranial magnetic stimulation (STMS) for the acute treatment of migraine
por: Bhola, R, et al.
Publicado: (2014)

Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM)
por: Lipton, Richard B, et al.
Publicado: (2015)

Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache
por: Marmura, Michael J., et al.
Publicado: (2021)

Migraine headache is present in the aura phase – a prospective study
por: Hansen, JM, et al.
Publicado: (2013)

The migraine postdrome: An electronic diary study
por: Giffin, Nicola J., et al.
Publicado: (2016)

A pilot study of the use of EEG-based synchronized Transcranial Magnetic Stimulation (sTMS) for treatment of Major Depression
por: Jin, Yi, et al.
Publicado: (2014)

Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial
por: Lipton, Richard B, et al.
Publicado: (2021)

Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study
por: Cowan, Robert P., et al.
Publicado: (2022)

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study
por: Saper, Joel R, et al.
Publicado: (2011)

Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review
por: Blumenfeld, Andrew M., et al.
Publicado: (2023)

Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension
por: Lipton, Richard B, et al.
Publicado: (2020)

Fake news believability: The effects of political beliefs and espoused cultural values
por: Gupta, Manjul, et al.
Publicado: (2023)

Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study
por: Goadsby, Peter J., et al.
Publicado: (2020)

Efficacy, Tolerability, and Safety of DFN‐15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study
por: Lipton, Richard B., et al.
Publicado: (2019)

Systematic review of outcomes and endpoints in preventive migraine clinical trials
por: McGinley, James S., et al.
Publicado: (2021)

Systematic review of outcomes and endpoints in acute migraine clinical trials
por: Houts, Carrie R., et al.
Publicado: (2021)

Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition
por: Diener, Hans-Christoph, et al.
Publicado: (2019)

Role of proton MR spectroscopy in spinal cord lesions: A guarded espousal
por: Agarwal, Arjit
Publicado: (2018)

The percent of chronic migraine patients who responded to onabotulinumtoxinA treatment per treatment cycle in the PREEMPT clinical program
por: Silberstein, S, et al.
Publicado: (2013)

Treatment preferences and the selection of acute migraine medications: results from a population-based survey
por: Lipton, Richard B., et al.
Publicado: (2004)

OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience
por: Chiang, Chia-Chun, et al.
Publicado: (2017)

Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial
por: Ashina, Messoud, et al.
Publicado: (2023)

Metabolic Syndrome and Migraine
por: Sachdev, Amit, et al.
Publicado: (2012)

Espoused implicit leadership and followership theories and emergent workplace relations: a factorial survey
por: Hesmert, Laura, et al.
Publicado: (2023)

Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM)
por: Kuruvilla, Deena E., et al.
Publicado: (2022)

Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Turkel, Catherine C., et al.
Publicado: (2023)

Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials
por: Ashina, Messoud, et al.
Publicado: (2021)

Treatment-Refractory Headache in the Setting of COVID-19 Pneumonia: Migraine or Meningoencephalitis? Case Report
por: Arca, Karissa N., et al.
Publicado: (2020)

TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points
por: Bigal, Marcelo E., et al.
Publicado: (2016)

The Influence of Migraine on Driving: Current Understanding, Future Directions, and Potential Implications of Findings
por: Tepper, Stewart J., et al.
Publicado: (2019)

Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications
por: Goadsby, Peter J, et al.
Publicado: (2020)

Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post‐Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial
por: Dodick, David W., et al.
Publicado: (2018)

GLADS: A gel-less approach for detection of STMS markers in wheat and rice
por: Vishwakarma, Gautam, et al.
Publicado: (2019)

STMS-YOLOv5: A Lightweight Algorithm for Gear Surface Defect Detection
por: Yan, Rui, et al.
Publicado: (2023)

The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine
por: Silberstein, Stephen D., et al.
Publicado: (2020)

Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult‐to‐Treat Migraine Headaches
por: Tepper, Stewart J., et al.
Publicado: (2019)

Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
por: Lipton, Richard B., et al.
Publicado: (2022)

Understanding the migraine treatment landscape prior to the introduction of calcitonin gene‐related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study
por: Kawata, Ariane K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1p736hg0u811phbomfbn84js8b